2012-10-10 01:13:57 - Fast Market Research recommends "NanoForm Therapeutics - Product Pipeline Review - 2012" from Global Markets Direct, now available

Global Market Direct's pharmaceuticals report, "NanoForm Therapeutics - Product Pipeline Review - 2012" provides data on the NanoForm Therapeutics's research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct's proprietary databases, NanoForm Therapeutics's corporate website, SEC filings, investor presentations and featured press releases, both from NanoForm Therapeutics and industry-specific third party sources, put together by Global Markets Direct's team.


Full Report Details at
- www.fastmr.com/prod/468565_nanoform_therapeutics_product_pipelin ..


Scope

* NanoForm Therapeutics - Brief NanoForm Therapeutics overview including business description, key information and

facts, and its locations and subsidiaries.
* Review of current pipeline of NanoForm Therapeutics human therapeutic division.
* Overview of pipeline therapeutics across various therapy areas.
* Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
* Product profiles for late stage and clinical stage products of NanoForm Therapeutics with complete description of the product's developmental history, mechanism of action, therapeutic class, target and major milestones.
* Recent updates of the NanoForm Therapeutics's pipeline in the last quarter.
* Key discontinued and dormant projects.
* Latest news and deals relating to the products.

Reasons to buy

* Evaluate NanoForm Therapeutics's strategic position with total access to detailed information on its product pipeline.
* Assess the growth potential of NanoForm Therapeutics in its therapy areas of focus.
* Identify new drug targets and therapeutic classes in the NanoForm Therapeutics's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
* Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
* Exploit collaboration and partnership opportunities with NanoForm Therapeutics.
* Avoid Intellectual Property Rights related issues.
* Explore the dormant and discontinued projects of NanoForm Therapeutics and identify potential opportunities in those areas.

Report Table of Contents:

Table of Contents
Table of Contents
List of Tables
List of Figures
NanoForm Therapeutics Snapshot
NanoForm Therapeutics Overview
Key Information
Key Facts
NanoForm Therapeutics - Research and Development Overview
Key Therapeutic Areas
NanoForm Therapeutics - Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products - Monotherapy
NanoForm Therapeutics - Pipeline Products Glance
NanoForm Therapeutics - Early Stage Pipeline Products
Pre-Clinical Products/Combination Treatment Modalities
Discovery Products/Combination Treatment Modalities
NanoForm Therapeutics - Drug Profiles
atorvastatin calcium
Product Description
Mechanism of Action
R&D Progress
candesartan cilexetil
Product Description
Mechanism of Action
R&D Progress
ezetimibe
Product Description
Mechanism of Action
R&D Progress
ibuprofen
Product Description
Mechanism of Action
R&D Progress
indomethacin
Product Description
Mechanism of Action
R&D Progress
olmesartan
Product Description
Mechanism of Action
R&D Progress
rosuvastatin calcium
Product Description
Mechanism of Action
R&D Progress
sildenafil citrate
Product Description
Mechanism of Action
R&D Progress
telmisartan
Product Description
Mechanism of Action
R&D Progress
zanamivir
Product Description
Mechanism of Action
R&D Progress
NanoForm Therapeutics - Pipeline Products by Route of Administration
NanoForm Therapeutics - Pipeline Products By Mechanism of Action
NanoForm Therapeutics - Company Statement
NanoForm Therapeutics - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

List of Tables
NanoForm Therapeutics, Key Information
NanoForm Therapeutics, Key Facts
NanoForm Therapeutics - Pipeline by Indication, 2012
NanoForm Therapeutics - Pipeline by Stage of Development, 2012
NanoForm Therapeutics - Monotherapy Products in Pipeline, 2012
NanoForm Therapeutics - Pre-Clinical, 2012
NanoForm Therapeutics - Discovery, 2012
NanoForm Therapeutics - Pipeline By Route of Administration, 2012
NanoForm Therapeutics - Pipeline Products By Mechanism of Action, 2012
NanoForm Therapeutics, Other Locations

List of Figures
NanoForm Therapeutics - Pipeline by Indication, 2012
NanoForm Therapeutics - Pipeline by Stage of Development, 2012
NanoForm Therapeutics - Monotherapy Products in Pipeline, 2012
NanoForm Therapeutics - Pipeline Products By Mechanism of Action, 2012

About Global Markets Direct

Global Markets Direct is a leading provider of global business intelligence and market analysis. It publishes a range of high quality company and market reports created by its large research and analysis capability and drawing from its extensive unique databases of industry-specific information. View more research from Global Markets Direct at www.fastmr.com/catalog/publishers.aspx?pubid=1033

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at www.fastmr.com or call us at 1.800.844.8156.